CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.

Ost-müük Alimera Sciences, Inc. - ALIM CFD

2.52
4.91%
  • Kokkuvõte
  • Ajaloolised andmed
  • Sündmused
  • Tuluaruanne
  • Bilanss
  • Rahavood
  • Omand
Kauplemistingimused
Hinnavahe 0.23
Pika positsiooni ööpäeva tasu

Long position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
-0.025457%
Lühikese positsiooni ööpäeva tasu

Short position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
0.003235%
Ööpäeva tasu aeg 21:00 (UTC)
Min kauplemise kogus 1
Valuuta USD
Tagatis 20%
Aktsiabörs United States of America
Kauplemise vahendustasu 0%

*Information provided by Capital.com

Võtmestatistika
Eelmine sulgemine* 2.65
Avatud* 2.6
Aastane muutus* -54.14%
Päeva ulatus* 2.51 - 2.6
52 nädala ulatus 1.30-7.92
Keskmine maht (10 päeva) 3.73M
Keskmine maht (3 kuud) 12.89M
Turukapitalisatsioon 19.59M
P/E suhtarv -100.00K
Ringluses olevad aktsiad 7.40M
Tulu 55.78M
EPS -2.44
Dividendid (% kasumist) N/A
Beeta 1.40
Järgmine tuluaruande kuupäev Jul 25, 2023

Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Sulgemishind Change (%) Avamishind High Low
May 31, 2023 2.67 0.19 7.66% 2.48 2.67 2.48
May 30, 2023 2.52 0.05 2.02% 2.47 2.55 2.47
May 26, 2023 2.49 0.08 3.32% 2.41 2.52 2.35
May 25, 2023 2.48 -0.02 -0.80% 2.50 2.51 2.37
May 24, 2023 2.41 0.23 10.55% 2.18 2.42 2.14
May 23, 2023 2.32 -0.19 -7.57% 2.51 2.55 2.21
May 22, 2023 2.45 0.28 12.90% 2.17 2.72 2.15
May 19, 2023 2.23 0.12 5.69% 2.11 2.30 2.02
May 18, 2023 2.34 -0.26 -10.00% 2.60 3.05 2.26
May 17, 2023 1.93 0.11 6.04% 1.82 1.94 1.78
May 16, 2023 1.79 0.21 13.29% 1.58 1.92 1.58
May 15, 2023 1.57 -0.03 -1.88% 1.60 1.68 1.56
May 12, 2023 1.56 -0.05 -3.11% 1.61 1.64 1.55
May 11, 2023 1.57 0.02 1.29% 1.55 1.64 1.48
May 10, 2023 1.52 -0.11 -6.75% 1.63 1.85 1.51
May 9, 2023 1.63 -0.14 -7.91% 1.77 1.77 1.63
May 8, 2023 1.73 -0.06 -3.35% 1.79 1.80 1.73
May 5, 2023 1.83 -0.05 -2.66% 1.88 2.04 1.76
May 4, 2023 1.84 0.10 5.75% 1.74 1.85 1.69
May 3, 2023 1.69 0.01 0.60% 1.68 1.78 1.66

Alimera Sciences, Inc. Events

Kellaaeg (UTC) (UTC) Riik Sündmus
Wednesday, July 12, 2023

Kellaaeg (UTC) (UTC)

13:30

Riik

US

Sündmus

Alimera Sciences Inc Annual Shareholders Meeting
Alimera Sciences Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Tuesday, July 25, 2023

Kellaaeg (UTC) (UTC)

12:30

Riik

US

Sündmus

Q2 2023 Alimera Sciences Inc Earnings Release
Q2 2023 Alimera Sciences Inc Earnings Release

Forecast

-

Previous

-
Monday, November 13, 2023

Kellaaeg (UTC) (UTC)

13:30

Riik

US

Sündmus

Q3 2023 Alimera Sciences Inc Earnings Release
Q3 2023 Alimera Sciences Inc Earnings Release

Forecast

-

Previous

-
Vaadake kõiki sündmusi
  • Aastas
  • Kvartalis
2022 2021 2020 2019 2018
Kogutulu 54.129 59.029 50.82 53.943 46.599
Tulu 54.129 59.029 50.82 53.943 46.599
Kulud, Kokku 7.977 7.03 6.941 6.626 4.308
Brutokasum 46.152 51.999 43.879 47.317 42.291
Kogu tegevuskulu 65.769 57.438 51.321 59.217 58.035
Müük/Üldine/admin kulud, kokku 38.858 35.843 32.036 38.958 38.042
Uuringud ja arendus 16.228 13.778 9.668 10.992 11.274
Depreciation / Amortization 2.706 2.579 2.676 2.641 2.645
Ootamatud kulutused (tulu) 0 -1.792 0 1.766
Tulud majandustegevusest -11.64 1.591 -0.501 -5.274 -11.436
Intressitulud (kulu), muud tulud, neto -5.789 -4.997 -4.906 -4.953 -4.84
Netotulu enne makse -18.079 -3.934 -5.407 -10.227 -16.276
Netotulu pärast makse -18.107 -4.372 -5.339 -10.443 -16.382
Netotulu enne erikulusid -18.107 -4.372 -5.339 -10.443 -16.382
Netotulu -18.107 -4.372 -5.339 -10.443 -16.382
Arvestatav tulu, v a erikulud -18.107 -4.372 -5.339 -10.443 21.948
Arvestatav tulu, koos erikuludega -18.107 -4.372 -5.339 -10.443 21.948
Jaotamisele kuuluv netotulu -18.107 -4.372 -5.339 -10.443 21.948
Keskmine jaotamisele kuuluv aktsia kohta 6.99685 6.59524 5.11766 4.7702 5.91587
Jaotatav EPS, v a erakorralised kulud -2.58788 -0.6629 -1.04325 -2.18921 3.71002
Jaotamisele kuuluv normaal-EPS -2.58788 -0.83951 -1.04325 -2.18921 3.90406
Other Operating Expenses, Total
Erakorralised kulud kokku 0 0
Total Adjustments to Net Income 0 38.33
Muud, neto -0.65 -0.528
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Kogutulu 13.546 14.029 13.598 14.604 11.898
Tulu 13.546 14.029 13.598 14.604 11.898
Kulud, Kokku 2.028 2.125 2.006 2.166 1.68
Brutokasum 11.518 11.904 11.592 12.438 10.218
Kogu tegevuskulu 16.848 16.137 17.009 16.578 16.045
Müük/Üldine/admin kulud, kokku 9.975 9.099 9.856 9.81 10.093
Uuringud ja arendus 4.164 4.23 4.483 3.932 3.583
Depreciation / Amortization 0.681 0.683 0.664 0.67 0.689
Tulud majandustegevusest -3.302 -2.108 -3.411 -1.974 -4.147
Intressitulud (kulu), muud tulud, neto -1.68 -1.621 -1.567 -1.345 -1.256
Netotulu enne makse -4.968 -3.781 -5.245 -3.098 -5.955
Netotulu pärast makse -4.968 -3.78 -5.257 -3.115 -5.955
Netotulu enne erikulusid -4.968 -3.78 -5.257 -3.115 -5.955
Netotulu -4.968 -3.78 -5.257 -3.115 -5.955
Arvestatav tulu, v a erikulud -4.982 -3.78 -5.257 -3.115 -5.955
Arvestatav tulu, koos erikuludega -4.982 -3.78 -5.257 -3.115 -5.955
Jaotamisele kuuluv netotulu -4.982 -3.78 -5.257 -3.115 -5.955
Keskmine jaotamisele kuuluv aktsia kohta 7.03223 7.00032 6.99658 6.99971 6.99074
Jaotatav EPS, v a erakorralised kulud -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Jaotamisele kuuluv normaal-EPS -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
Ootamatud kulutused (tulu) 0 0 0
Muud, neto 0.014 -0.052 -0.267 0.221 -0.552
Total Adjustments to Net Income -0.014
  • Aastas
  • Kvartalis
2022 2021 2020 2019 2018
Käibevarad kokku 29.413 42.16 34.906 32.745 34.848
Raha ja lühiajalised investeeringud 5.274 16.51 11.208 9.426 13.043
Raha ja ekvivalendid 5.274 16.51 11.208 9.426 13.043
Laekumata arved, neto 19.612 19.128 17.2 19.331 17.259
Accounts Receivable - Trade, Net 19.612 19.128 17.2 19.331 17.259
Total Inventory 1.605 2.679 2.746 1.39 2.405
Prepaid Expenses 2.892 3.809 3.718 2.565 2.109
Other Current Assets, Total 0.03 0.034 0.034 0.033 0.032
Total Assets 42.602 58.52 50.855 50.309 54.108
Property/Plant/Equipment, Total - Net 3.92 4.493 2.358 2.047 1.355
Property/Plant/Equipment, Total - Gross 7.981 7.923 6.305 5.858 4.967
Accumulated Depreciation, Total -4.061 -3.43 -3.947 -3.881 -3.612
Intangibles, Net 8.957 10.897 12.838 14.783 16.723
Other Long Term Assets, Total 0.129 0.137 0.753 0.734 1.182
Total Current Liabilities 39.732 12.592 12.348 12.048 10.234
Accounts Payable 10.088 8.706 7.461 7.077 6.355
Accrued Expenses 3.998 3.617 3.197 4.716 3.643
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 25.646 0.269 1.69 0.255 0.236
Other Current Liabilities, Total
Total Liabilities 63.41 61.125 58.833 54.754 51.386
Total Long Term Debt 18.683 43.08 42.922 38.752 38.178
Long Term Debt 18.683 43.08 42.408 38.658 37.873
Capital Lease Obligations 0.514 0.094 0.305
Other Liabilities, Total 4.995 5.453 3.563 3.954 2.974
Total Equity -20.808 -2.605 -7.978 -4.445 2.722
Preferred Stock - Non Redeemable, Net 19.227 19.227 19.227 30.344 30.344
Common Stock 0.07 0.069 0.057 0.05 0.701
Additional Paid-In Capital 378.238 377.229 365.83 350.117 346.108
Retained Earnings (Accumulated Deficit) -415.388 -397.281 -392.539 -383.863 -373.42
Other Equity, Total -2.955 -1.849 -0.553 -1.093 -1.011
Total Liabilities & Shareholders’ Equity 42.602 58.52 50.855 50.309 54.108
Total Common Shares Outstanding 6.99551 6.93515 5.71937 4.96595 4.67193
Total Preferred Shares Outstanding 0.6 0.6 0.6 0.61015 0.61015
Long Term Investments 0.183 0.833
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Käibevarad kokku 35.675 29.413 29.76 33.073 34.753
Raha ja lühiajalised investeeringud 13.086 5.274 5.514 7.859 9.946
Raha ja ekvivalendid 13.086 5.274 5.514 7.859 9.946
Laekumata arved, neto 18.433 19.612 19.142 20.319 18.776
Accounts Receivable - Trade, Net 18.433 19.612 19.142 20.319 18.776
Total Inventory 1.215 1.605 1.786 1.656 2.452
Prepaid Expenses 2.91 2.892 3.29 3.208 3.546
Other Current Assets, Total 0.031 0.03 0.028 0.031 0.033
Total Assets 48.239 42.602 43.429 47.574 49.931
Property/Plant/Equipment, Total - Net 3.757 3.92 3.87 3.938 4.343
Intangibles, Net 8.479 8.957 9.446 9.935 10.419
Other Long Term Assets, Total 0.131 0.129 0.118 0.126 0.134
Total Current Liabilities 14.173 39.732 34.01 25.431 17.006
Accounts Payable 9.669 10.088 8.706 7.614 6.604
Accrued Expenses 4.241 3.998 3.661 3.316 3.046
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.263 25.646 21.643 14.501 7.356
Total Liabilities 67.155 63.41 61.507 59.909 58.534
Total Long Term Debt 44.312 18.683 22.492 29.297 36.245
Long Term Debt 44.152 18.683 22.492 29.297 36.245
Capital Lease Obligations 0.16
Other Liabilities, Total 8.67 4.995 5.005 5.181 5.283
Total Equity -18.916 -20.808 -18.078 -12.335 -8.603
Preferred Stock - Non Redeemable, Net 7.728 19.227 19.227 19.227 19.227
Common Stock 0.074 0.07 0.07 0.07 0.07
Additional Paid-In Capital 378.146 378.238 378.005 377.847 377.541
Retained Earnings (Accumulated Deficit) -402.081 -415.388 -411.608 -406.351 -403.236
Other Equity, Total -2.783 -2.955 -3.772 -3.128 -2.205
Total Liabilities & Shareholders’ Equity 48.239 42.602 43.429 47.574 49.931
Total Common Shares Outstanding 7.39159 6.99551 6.99802 6.99546 6.99265
Total Preferred Shares Outstanding 0.012 0.6 0.6 0.6 0.6
Long Term Investments 0.197 0.183 0.235 0.502 0.282
Other Current Liabilities, Total
  • Aastas
  • Kvartalis
2022 2021 2020 2019 2018
Netotulu/algväärtus -18.107 -4.372 -5.339 -10.443 -16.382
Raha majandustegevusest -9.975 -3.224 -2.193 -4.152 -11.553
Raha majandustegevusest 2.706 2.579 2.676 2.641 2.645
Deferred Taxes 0.116 0.61 0.031 0.454 -0.653
Mittelikviidsed varad 2.621 -0.692 1.829 3.377 7.084
Cash Taxes Paid 0.232 0.112 0.11 0.239 0.239
Makstud intressid 4.489 4.302 4.556 4.419 3.571
Muutused tööjõus 2.689 -1.349 -1.39 -0.181 -4.247
Tulu investeeringutelt -0.255 -0.621 -0.62 -0.174 -0.175
Kapitalikulutused -0.255 -0.621 -0.62 -0.174 -0.175
Rahavood investeeringutelt -0.302 9.823 3.882 0.869 0.95
Rahavoogudesse investeerimine -0.113 0 -0.019 -2.227 -3.808
Aktsiate emiteerimine (tagasiost), neto 0.1 10.044 0.049 0.902 0.085
Laenu väljastamine (kustutamine), neto -0.289 -0.221 3.852 2.194 4.673
Muutused valuutakursside kõikumisest -0.708 -0.676 0.714 -0.159 -0.248
Rahaline kogumuutus -11.24 5.302 1.783 -3.616 -11.026
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -4.968 -18.107 -14.327 -9.07 -5.955
Cash From Operating Activities -2.209 -9.975 -9.724 -7.811 -6.213
Cash From Operating Activities 0.681 2.706 2.023 1.359 0.689
Non-Cash Items 0.507 2.621 2.095 1.318 1.027
Cash Taxes Paid 0 0.232 0.224 0.182 0.018
Cash Interest Paid 1.354 4.489 3.253 2.145 1.061
Changes in Working Capital 1.571 2.689 0.485 -1.418 -1.974
Cash From Investing Activities -0.009 -0.255 -0.171 -0.041 -0.149
Capital Expenditures -0.009 -0.255 -0.171 -0.041 -0.149
Cash From Financing Activities 9.998 -0.302 -0.109 -0.164 -0.062
Financing Cash Flow Items -3.123 -0.113
Issuance (Retirement) of Debt, Net 2.373 -0.289 -0.164 -0.204 -0.062
Foreign Exchange Effects 0.033 -0.708 -0.998 -0.638 -0.141
Net Change in Cash 7.813 -11.24 -11.002 -8.654 -6.565
Issuance (Retirement) of Stock, Net 10.748 0.1 0.055 0.04
Deferred Taxes 0.116
Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
Velan Capital Investment Management LP Investment Advisor/Hedge Fund 22.4131 1659654 1401901 2023-05-17 MED
Ocumension Therapeutics Corporation 15.4621 1144945 0 2023-04-24 LOW
Morgan Stanley & Co. LLC Research Firm 8.9243 660832 0 2023-03-31 MED
Caligan Partners, LP Hedge Fund 6.4657 478777 0 2023-05-17 MED
Eiswirth (Richard S Jr) Individual Investor 4.3555 322518 500 2023-04-24 LOW
HOOPP Investment Management Pension Fund 3.3762 250000 0 2023-03-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0071 148624 0 2023-03-31 LOW
Ashman Philip Individual Investor 1.8004 133315 0 2023-04-24 MED
Holland (David R) Individual Investor 1.4704 108880 500 2023-04-24 LOW
Renaissance Technologies LLC Hedge Fund 1.3693 101394 -1100 2023-03-31 HIGH
Skibsted (Russell L) Individual Investor 1.0196 75500 58000 2023-03-26 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5167 38262 0 2023-03-31 LOW
Jones (John Philip) Individual Investor 0.4347 32186 372 2022-10-31
Millennium Management LLC Hedge Fund 0.3884 28762 16799 2023-03-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.2639 19542 0 2023-03-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.2471 18300 0 2023-03-31 LOW
Perritt Capital Management, Inc. Investment Advisor 0.2431 18000 0 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.175 12962 438 2023-03-31 LOW
J.P. Morgan Securities LLC Research Firm 0.14 10364 9838 2023-03-31 MED
Snisarenko (John) Individual Investor 0.135 10000 0 2023-04-24 LOW

Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

Capital.com Group

535K+

Kauplejad

87K+

Igakuiste aktiivsete klientide arv

$113M+

Igakuine investeerimise maht

$64M+

Igakuiselt välja võetud

Kauplemiskalkulaator

Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).

Kauplemise vahendustasu
0
  • 1:1
Finantsvõimendus
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind

Close

Lühike Pikk

Alimera Sciences, Inc. Company profile

Ettevõttest Alimera Sciences, Inc.

Alimera Sciences, Inc. on farmaatsiaettevõte. Ettevõte tegeleb retsepti alusel väljastatavate silmaravimite turustamise ja arendamisega. See keskendub silma tagakülge ehk võrkkesta mõjutavatele haigustele. Ettevõtte kaubanduslik toode ILUVIEN on intravitreaalne implantaat, mis ravib patsiente, manustades silma kuni 36 kuu jooksul pidevat mikrodoosi ravimiteta kortikosteroidi fluotsinoloonatsetoniidi (FAc). Ettevõte tegeleb diabeetilise makulaödeemi (DME) ravi arendamisega. DME on võrkkesta haigus, mis mõjutab diabeeti põdevaid inimesi ja võib põhjustada tõsist nägemise kaotust ja pimedaks jäämist. ILUVIENi saab kasutada ka tagumise silma tagumise segmendi (NIU-PS) retsidiivse mitteinfektsioosse uveiidi ägenemise vältimiseks. Ettevõte turustab ILUVIENi otse Ameerika Ühendriikides, Saksamaal, Ühendkuningriigis, Portugalis ja Iirimaal.

Industry: Biopharmaceuticals

Ste 290
6120 Windward Parkway
ALPHARETTA
GEORGIA 30005
US

Tuluaruanne

  • Annual
  • Quarterly

Teised on vaadanud veel

Oil - Crude

70.20 Price
+3.700% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0204%
Lühikese positsiooni ööpäeva tasu -0.0016%
Ööpäeva tasu aeg 21:00 (UTC)
Hinnavahe 0.03

BTC/USD

26,812.80 Price
-1.390% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0616%
Lühikese positsiooni ööpäeva tasu 0.0137%
Ööpäeva tasu aeg 21:00 (UTC)
Hinnavahe 60.00

Gold

1,976.06 Price
+0.690% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0183%
Lühikese positsiooni ööpäeva tasu 0.0101%
Ööpäeva tasu aeg 21:00 (UTC)
Hinnavahe 0.30

US100

14,447.50 Price
+1.410% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0255%
Lühikese positsiooni ööpäeva tasu 0.0032%
Ööpäeva tasu aeg 21:00 (UTC)
Hinnavahe 1.8

Kas otsite jätkuvalt vahendajat, keda saab usaldada?

Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist